Summit Therapeutics (SMMT) Research & Development (2014 - 2026)
Summit Therapeutics' Research & Development was $169.13 million in Q3 2026, up 29.0% from $131.1 million a year earlier and up 7.2% from the prior quarter.
Powered by 
Analysis
Summit Therapeutics (SMMT) Research & Development (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Summit Therapeutics' Research & Development was $606.77 million through Sep 30, 2026, up 37.4% year-over-year; for FY2025, it was $537.67 million, up 256.6% from FY2024.
- Research & Development has now increased for three consecutive years, with a five-year compound annual growth rate of 58.8% (FY2020 to FY2025).
- In earlier years, Research & Development was $150.78 million in FY2024 (+153.5%), $59.47 million in FY2023 (+14.4%), $52 million in FY2022 (-39.1%) and $85.35 million in FY2021 (+60.2%).
- The Q3 2026 figure marks the highest quarterly Research & Development since Q2 2025.
- Compared with a year earlier, Research & Development was higher in seven of the last eight quarters, with growth averaging 168.3%.
- The best year-over-year quarter for Research & Development over five years was Q2 2025 (growth of 575.4%); the worst was Q4 2022 (a decline of 76.7%).
- Per Business Quant data, SMMT's Research & Development in the three quarters before Q3 2026 was $157.73 million (Q2 2026), $132.62 million (Q1 2026) and $147.29 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Summit Therapeutics | 14.26 Bn | 11.63 Bn | - | 169.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 169.13 Mn |
| Jun 30, 2026 | 157.73 Mn |
| Mar 31, 2026 | 132.62 Mn |
| Dec 31, 2025 | 147.29 Mn |
| Sep 30, 2025 | 131.10 Mn |
| Jun 30, 2025 | 208.02 Mn |
| Mar 31, 2025 | 51.27 Mn |
| Dec 31, 2024 | 51.38 Mn |
| Sep 30, 2024 | 37.72 Mn |
| Jun 30, 2024 | 30.80 Mn |
| Mar 31, 2024 | 30.87 Mn |
| Dec 31, 2023 | 24.81 Mn |
| Sep 30, 2023 | 15.32 Mn |
| Jun 30, 2023 | 9.45 Mn |
| Mar 31, 2023 | 9.88 Mn |
| Dec 31, 2022 | 5.39 Mn |
| Sep 30, 2022 | 17.05 Mn |
| Jun 30, 2022 | 9.01 Mn |
| Mar 31, 2022 | 20.56 Mn |
| Dec 31, 2021 | 23.11 Mn |
API Access
Summit Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();